Cancer Immunology

癌症免疫学

• 批准号: 7714189
• 负责人: Michael Loran Dustin
• 金额: $ 1.45万
• 依托单位: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-04-18 至 2013-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7714189
• 关键词: Area; Biology; Cancer Immunology Science; Diagnosis; Faculty; Funding; Goals; Growth; Immune system; Immunology; Immunotherapy; Institution; Lymphoid Cell; Mission; Myelogenous; Neoplasms; Pathology; Publications; Recruitment Activity; System; Tumor Biology; cancer immunology function; malignant breast neoplasm; medical schools; melanoma; member; neuro-oncology; programs; tumor

The Cancer Immunology Program is one of the longstanding components of the NYUCI, with 38 members from 9 Departments. This program has recently been expanded by the vigorous recruitment in Immunology conducted by the NYUCI and also the Department of Pathology, to new or newly renovated space. 12 faculty have been added to the Program in the past year; 9 of these are new recruits brought to NYU School of Medicine from outstanding institutions such as Harvard, Stanford, Yale, UCSF, and others. Goals of the Cancer Immunology Program are: 1) to understand the biology of, more effectively diagnose, and develop treatments for neoplasms arising from cells of the lymphoid and myeloid system, 2) to understand the biology of tumor rejection, including the mechanisms used by tumors to evade the immune system; 3) to effectively manipulate the immune system to promote immunotherapy of tumors. The program is subdivided into three thematic areas reflecting this tripartite mission. Members of this program collaborate extensively with other.NYUCI Programs, especially Growth Control, Breast Cancer, Neurooncology, and Melanoma. The Cancer Immunology Group has been highly productive, generating over 319 publications from 2002-2006 and has increased outside funding from $4.8 M in 2002 to $10.4 M in 2006. Total funding has increased from $7,128,048 to $11,674,122. Membership has increased from 17 to 38. Total publications for the past five years include 319 of which 4% are intra-programmatic and 15% are interprogrammatic.

癌症免疫学计划是Nyuci的长期组成部分之一，有38个成员 来自9个部门。该计划最近已通过免疫学的剧烈招募扩大 由Nyuci以及病理学系进行，用于新的或新装修的空间。 12 在过去的一年中，该计划已添加到该计划中；其中9个是带到纽约大学学校的新兵 来自哈佛，斯坦福大学，耶鲁大学，UCSF等杰出机构的医学。目标的目标 癌症免疫学计划是：1）了解，更有效地诊断和发展的生物学 由淋巴样细胞和髓样系统引起的肿瘤治疗，2） 肿瘤排斥的生物学，包括肿瘤逃避免疫系统的机制； 3）到 有效地操纵免疫系统以促进肿瘤的免疫疗法。该程序被细分 分为三个主题领域，反映了这一三方任务。该计划的成员广泛合作 与其他。NYUCI计划，尤其是生长控制，乳腺癌，神经科学和黑色素瘤。这 癌症免疫学小组的生产力很高，从2002- 2006年产生了319多个出版物 并已将外部资金从2002年的4.8 m增加到2006年的10.4 m。 总资金从7,128,048美元增加到11,674,122美元。会员资格已从17增加到38个。 过去五年中的总出版物包括319个，其中4％是概括性的，有15％是译本。